BIOREGENX, INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$411K
↓-19.2% -$98Kvs FY2024
Total Liabilities
$5M
↑+27.3% +$1Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $411K | $509K |
| Current Assets | $251K | $308K |
| Cash | $0 | $58K |
| ST Investments | $0 | $0 |
| Receivables | $40K | $15K |
| Inventory | $107K | $111K |
| Other Current | $105K | $123K |
| Non-Current Assets | $160K | $201K |
| PPE | $160K | $201K |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $0 | $0 |
| Total Liab+Eq | $411K | $509K |
| Current Liab. | $4M | $4M |
| Accounts Payable | $616K | $427K |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $60K | $197K |
| Other CL | $3M | $3M |
| Non-Current Liab. | $882K | $255K |
| Long-Term Debt | $1M | $1M |
| Other LT Liab. | $0 | $0 |
| Equity | $-5M | $-3M |
| Retained Earnings | $37M | $36M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · BRGX · Comparing FY2025 vs FY2024